Disclosed is the use of balsalazide or balsalazide disodium in the manufacture of a medicament for treating gastrointestinal disease in a subject wherein the medicament is formulated for administration of about 6.6 grams per day of balsalazide or balsalazide sodium and is formulated for two daily doses.